Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
Between the Biotech Waves
00:00
Are You Seeing a Cash Runway?
There's actually 250 that have distressed runways where they're approaching 12 months of cash. And so, you know, what we've seen is a number of things to try and deal with that. But companies are doing making the tough choice and doing diluted financings. And what we're seeing is when you solve for the cash runway, companies tend to perform better.
Transcript
Play full episode
